Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Keybanc Maintains Underweight on Avangrid, Lowers Price Target to $35

Keybanc Maintains Underweight on Avangrid, Lowers Price Target to $35

Keybanc analyst Sophie Karp maintains Avangrid (NYSE:AGR) with a Underweight and lowers the price target from $41 to $35.

byBenzinga Newsdesk

October 20, 2022

1 minute read

Keybanc analyst Sophie Karp maintains Avangrid (NYSE:AGR) with a Underweight and lowers the price target from $41 to $35.

Seagen’s Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa’s Current Market

By Vandana Singh

August 16, 2:12 PM

Earlier today, Seagen Inc (NASDAQ: SGEN) announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla) met its primary endpoint of

PFE

Analyst Ratings

Where Chevron Stands With Analysts

By Benzinga Insights

August 17, 10:00 AM

Chevron (NYSE:CVX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

CVX

P/E Ratio Insights for Adobe

By Benzinga Insights

July 7, 3:16 PM

In the current session, the stock is trading at $487.94, after a 1.38% increase. Over the past month,…

ADBE

Deutsche Bank Downgrades International Paper to Sell, Lowers Price Target to $29

By Benzinga Newsdesk

October 18, 7:19 AM

Deutsche Bank analyst Debbie Jones downgrades International Paper (NYSE:IP) from Hold to Sell and lowers the price target from $44 to $29.

Keybanc Maintains Underweight on Avangrid, Lowers Price Target to $35

Related Posts

Seagen’s Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa’s Current Market

Where Chevron Stands With Analysts

P/E Ratio Insights for Adobe

Deutsche Bank Downgrades International Paper to Sell, Lowers Price Target to $29